1 / 11

MS in Iceland MS ID Meaningful patient involvement

MS in Iceland MS ID Meaningful patient involvement. Dr. Sverrir Bergmann. MS ID EMSP and EU Standardized MS (European) register General Informative

mikko
Download Presentation

MS in Iceland MS ID Meaningful patient involvement

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. MS in Iceland MS ID Meaningful patient involvement Dr. Sverrir Bergmann

  2. MS ID EMSP and EU Standardized MS (European) register General Informative Combined Purposes Participiants: Germany Great Britain Iceland Poland Rumania Spain Pilot study 2008 – manuscript accepted

  3. MS ID Medical register Socio economic register Meaningful patient involvement Epidemiological data Code of Good Practice Cost/benefit Patient understanding

  4. Iceland 103.000 squarekilometers Population 320.000 Reykjavík/SW area 230.000 Other areas 90.000 Young nation Irish monks 600 Vikings 874

  5. I C E L A N D - MS • Epidemiological studies: 1962, 71, 73, 80, 84, 94, 98, 2009 • Prevalence: 1.4/1000 MS ID already registered cases 380 • MS ID to be registered cases 60 • Incidence: 5-7/100.000 per year • No epidemic period • No relation to epidemics - including measles • Equally spread – no clusters • No relation to occupation • Familial incidence: 10% of families – • - 2 or >2 case in 3 generations • M/FE ratio 32/68

  6. I C E L A N D - MS Onset age: 10-19 years of age 15% 20-29 - - - 45% 30-39 - - - 28% 40-49 - - - 10% > 50 - - - 2% Mean onset age 29.4 years of age Onset symptoms: Motor 34% Sensory 34% Optic neuritis 18% Other 14% Encephalopathia Fatigue Psychiatric features Pain Epilepsy

  7. I C E L A N D - MS Disease type: (or course) CIS 2% R/R65% R/R + secondary progression 27% Primary progressive 6% EDSS (Mean > 20 years) 0 - 2.5 42% 2.5 - 4.5 29% 4.5 - 7.5 21% 8.0 + 8%

  8. I C E L A N D - MS ID • Medical register • Epidemiological data • Medical/Paramedical state: All PwMS under the care of neurologist All necessary investigatory facilities available All treatment available – symptomatic and DMT All necessary paramedical treatment available Easy access everywhere in the country • Waiting time in days only for neurological • consultation and future care and for • investigations and for all types of treatment • Currently 45% PwMS on DMT

  9. I C E L A N D - MS ID Social register Registration by PwM Marital state Education Occupation Course of disease Personal assessment Medical treatment Paramedical treatment Social assistance Home help Home care Facilities in general Social activity Understanding Disease Condition Symptoms Treatment

  10. I C E L A N D - MS ID PwMS involvement/co-operation PwMS own registration Subsequent registration review with neurologist GAIN(S)Information More reliable Understanding Disease Investigations Treatment Live Adjustment Condition Care Co-operation Treatment Active involvement Treatment Organization

  11. TAKK !

More Related